Clinical trial
Differences in Immunologic Response to Cryoablation Versus Radiofrequency Ablation in the Treatment of Renal Cell Carcinoma
NCT03409224 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Differences in Immunologic Response to Cryoablation Versus Radiofrequency Ablation in the Treatment of Renal Cell Carcinoma
- Lead sponsor
- University of California, Irvine
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2003
- Completion date
- April 30, 2019
- Enrollment
- 53 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
immune response to 3 approaches